Neurology
Researchers' data from South Korea and Japan advance neurology research
Published in Cancer Weekly, June 12th, 2006
Study 1: Neuroblastoma could be inhibited by arsenic trioxide (As2 O3 ).
According to recent research published in the journal Pediatric Hematology and Oncology, "Neuroblastoma, characterized by heterogeneous cell population, is a common solid tumor in childhood and some malignant neuroblastomas are refractory to conventional chemotherapy. Recently, treatment with As2 O3 was found effective in the treatment of acute promyelocytic leukemia as well as neuroblastoma cells by inducing apoptosis."
"To define the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-12)
More Articles from Cancer Weekly
- Apoptosis
Melanoma apoptosis triggered by novel Bcl-x splice product, Bcl-x(AK) - Breast Cancer
Breast cancer risk increased in developing countries due to circadian disruption - Hurthle Cell Cancer
Encapsulated Hurthle cell carcinoma recurrence predicted by presence of 4 foci of vascular invasion - Neuroblastoma
Poor neuroblastoma outcome could be due to high-level MRP1 expression - Acoustic Neuroma
Acoustic neuroma patients' quality of life used in timing of surgery - Adenocarcinoma
Adenocarcinoma of esophagus and gastroesophageal junction linked to alteration of 1q and 8p genes - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
